ResMed share price and momentum signal (NYSE: RMD)
NYSE · Health Care · Data to 4 Nov 2026
Current signal
Low Signal
The probability is the model's estimate that the closing price 34 calendar days later will be above its 150-day exponential moving average. High is 52.5% and above, Moderate from 50.5%. How the signal works.
Price and model probability, last 12 months
Last 10 trading days as a table
| Date | Adjusted close | Model probability |
|---|---|---|
| 4 Nov 2026 | $240.51 | 55.2% |
| 3 Nov 2026 | $227.08 | 52.7% |
| 2 Nov 2026 | $232.94 | 53.7% |
| 30 Oct 2026 | $229.94 | 53.3% |
| 29 Oct 2026 | $252.83 | 79.0% |
| 28 Oct 2026 | $250.17 | 75.5% |
| 27 Oct 2026 | $250.80 | 78.8% |
| 26 Oct 2026 | $253.20 | 81.1% |
| 23 Oct 2026 | $252.86 | 81.2% |
| 22 Oct 2026 | $253.06 | 81.5% |
Key figures
- 1 month
- +7.9%
- 3 months
- +7.4%
- 6 months
- +14.7%
- 12-month high
- $275.96 9 Feb 2026
- 12-month low
- $186.29 17 Jun 2026
- From the high
- -12.8%
Changes are in adjusted closing price to 4 Nov 2026; the 12-month range covers trading since 4 Nov 2025.
Research on ResMed
No research notes on ResMed yet.
Other Health Care stocks
- Revvity High Signal
- Steris Low Signal
- Stryker Low Signal
- UnitedHealth Group Low Signal
- Universal Health Services Low Signal
- Abbott Laboratories Moderate Signal
- Amgen High Signal
- Baxter International Low Signal
Questions about ResMed
What is the current PredictivePick momentum signal for ResMed?
As of 4 Nov 2026, ResMed (RMD) has a Low Signal. Its model probability, averaged over the last 5 trading days, is 58.8%. The signal is High at 52.5% and above, Moderate from 50.5%, and Low below that.
How has the ResMed share price moved recently?
Based on adjusted closing prices to 4 Nov 2026, ResMed has changed +7.9% over one month, +7.4% over three months and +14.7% over six months. Since 4 Nov 2025 it has traded between $186.29 and $275.96.
Which sector is ResMed in?
ResMed is classified under Health Care. Other Health Care stocks PredictivePick covers include Revvity, Steris, Stryker, UnitedHealth Group, Universal Health Services, Abbott Laboratories, Amgen, Baxter International.
What does the PredictivePick signal for ResMed measure?
It is the model's estimated probability that the stock's closing price 34 calendar days later will be above its 150-day exponential moving average. It is a statistical estimate, not a price target or a recommendation. Signals are model estimates calculated from publicly available market data. They are not investment advice, do not represent actual trading results, and are not claimed to be accurate or complete.
Signals are model estimates calculated from publicly available market data. They are not investment advice, do not represent actual trading results, and are not claimed to be accurate or complete. See the full disclaimer.